SGLT2 Inhibitors in Focal Segmental Glomerulosclerosis SGLT2 Inhibitors in Focal Segmental Glomerulosclerosis

This editorial explores the question of whether SGLT2 inhibitors could offer a potential treatment option for focal segmental glomerulosclerosis.Nephrology Dialysis Transplantation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news